Mitochondrial Replacement Therapy image

JAMA Forum, February 14, 2017
Eli Y. Adashi and I. Glenn Cohen (Faculty Director)


Read the full article

From the article:

Mitochondrial replacement therapy, an experimental approach that takes aim at maternally inherited mitochondrial diseases, is on the verge of being implemented in the United Kingdom, almost 2 years after it received approval from the UK Parliament. In a ruling issued on December 15, 2016, the UK Human Fertilisation & Embryology Authority (HFEA) concluded that mitochondrial replacement therapy “can be used cautiously for risk reduction treatments in certain cases where alternative treatments would be of little or no benefit to mothers at risk of passing mitochondrial disease onto their children.”

Read the full article here!

bioethics biotechnology health law policy i. glenn cohen international regulation research